Arabic Arabic English English French French German German
dark

Medigen Vaccine Biologics Announces Launch of Its COVID-19 Vaccine MVC-COV1901 Adjuvanted with Dynavax’s CpG 1018 Adjuvant

Medigen Vaccine Biologics Corporation today announced the rollout of its COVID-19 vaccine, MVC-COV1901. Approximately 600,000 people are anticipated to receive the Medigen vaccine this week. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member

Next Post

LUNGevity Foundation and Partner Hamoui Family Foundation Issue 2022 Request for Applications for RET-Positive Clinical Lung Cancer Research

Related Posts
Total
0
Share